Analyst upgrades: WX, XOM and LPNT
Posted Mar 14th 2008 11:22AM by Eric Buscemi
Filed under: Analyst Reports, Analyst Upgrades and Downgrades, Exxon Mobil (XOM), Boeing Co (BA), Cardinal Health (CAH)
.gif)
MOST NOTEWORTHY: WuXi Pharma, ExxonMobil and LifePoint Hospitals were today's noteworthy upgrades:
- Jefferies upgraded shares of WuXi Pharma (NYSE: WX) to Buy from Hold as they believe the risk/reward is much improved following the recent weakness. They think the company's 2008 guidance is achievable.
- Credit Suisse raised ExxonMobil (NYSE: XOM) to Outperform from Neutral as they believe the rise in crude oil means analyst estimates are too low.
- Goldman sees upside to hospital stocks given low valuations and expectations. The firm upgraded LifePoint Hospitals (NASDAQ: LPNT) to Buy from Neutral and named it a top pick along with previous top pick Cardinal Health (NYSE: CAH).
OTHER UPGRADES:
- Goldman added NDS Group (NASDAQ: NNDS) to their Conviction Buy List and upgraded shares to Buy from Neutral.
- Morgan Stanley raised Boeing (NYSE: BA) to Overweight from Equal Weight.
- JP Morgan added Sherwin-Williams (NYSE: SHW) to the Focus List.
Tags: analyst, ba, boeing, cah, cardinal health, CardinalHealth, exxon mobil, ExxonMobil, lifepoint, lpnt, nds group, NdsGroup, nnds, sherwin-williams, shw, upgrade, wuxi, wx, xom
Tax Reform in This Election Year: It's Not Likely
Which Credit Card Rewards Does the IRS Care About?
Goldman Earnings Sink After Buffett Dividend
Johnson & Johnson's Income Falls 23%
Burberry Shares Leap on Sales Update
